| Version |
1.0 |
| Creation Date |
2009-03-06 18:58:06 |
| Update Date |
2010-03-18 21:52:24 |
| Accession Number |
T3D0117 |
| Name |
Manganese |
| Compound Type |
- Cosmetic Toxin
- Inorganic Compound
- Manganese Compound
- Metal
|
| Description |
Manganese is a naturally occurring metal with the symbol Mn and the atomic number 25. It does not occur naturally in its pure form, but is found in many types of rocks in combination with other substances such as oxygen, sulfur, or chlorine. Manganese occurs naturally in most foods and small amounts are needed to stay healthy, as manganese ions act as cofactors for a number of enzymes. Manganese is used principally in steel production to improve hardness, stiffness, and strength. It may also be used as an additive in gasoline to improve the octane rating of the gas. Manganese ions have various colors and are used industrially as pigments. (R441, R442) |
| Synonyms |
- Colloidal manganese
- Cutaval
- Dienol
- Magnacat
- Mangan [polish]
- Mangan nitridovany [czech]
- Manganese fume
- Manganese metal alloy
- Manganese, elemental
- Manganeso
- Manganum
- Oligostim manganese
- Tripart liquid manganese
- Tronamang
- Tronamang electrolytic manganese metal
|
| Chemical IUPAC Name |
manganese(2+) ion |
| Chemical Formula |
Mn |
| Chemical Structure |
 |
| CAS Registry Number |
7439-96-5 |
| InChI Identifier |
InChI=1S/Mn/q+2 |
| InChI Key |
InChIKey=WAEMQWOKJMHJLA-UHFFFAOYSA-N |
| PubChem Compound ID |
23930  |
| KEGG ID |
C00034  |
| UniProt ID |
Not Available |
| OMIM ID |
153550
173470  |
| ChEBI ID |
18291  |
| BioCyc ID |
MN%2b3  |
| SuperToxic ID |
Not Available |
| CTD ID |
D008345  |
| Stitch ID |
Manganese  |
| DrugBank ID |
Not Available |
| PDB ID |
Not Available |
| ACToR ID |
6475 |
| Wikipedia Link |
http://en.wikipedia.org/wiki/Manganese  |
| Monoisotopic Mass |
54.93805 |
| MOL File |
Show |
| PDB File |
Show |
| SDF File |
Show |
| SMILES |
[Mn++] |
| Appearance |
Not Available |
| Melting Point |
1244 °C |
| Solubility |
Not Available |
| Predicted LogP |
-0.156 |
| Route of Exposure |
Oral (R441) ; inhalation (R441) |
| Mechanism of Action |
Manganese is a cellular toxicant that can impair transport systems, enzyme activities, and receptor functions. It primarily targets the central nervous system, particularily the globus pallidus of the basal ganglia. It is believed that the manganese ion, Mn(II), enhances the autoxidation or turnover of various intracellular catecholamines, leading to increased production of free radicals, reactive oxygen species, and other cytotoxic metabolites, along with a depletion of cellular antioxidant defense mechanisms, leading to oxidative damage and selective destruction of dopaminergic neurons. In addition to dopamine, manganese is thought to interact with other neurotransmitters, such as GABA and glutamate. Manganese overwhelms the manganese superoxide dismutase and produce oxidative damage. The neurotoxicity of Mn(II) has also been linked to its ability to substitute for Ca(II) under physiological conditions. It can enter mitochondria via the calcium uniporter and inhibit mitochondrial oxidative phosphorylation. It may also inhibit the efflux of Ca(II), which can result in a loss of mitochondrial membrane integrity. Mn(II) has been shown to inhibit mitochondrial aconitase activity to a significant level, altering amino acid metabolism and cellular iron homeostasis. (R441) |
| Metabolism |
Manganese is mainly absorbed via ingestion, but can also be inhaled. It binds to alpha-2-macroglobulin, albumin, or transferrin in the plasma and is distributed to the brain and all other mammalian tissues, though it tends to accumulate more in the liver, pancreas, and kidney. Manganese exists in a number of oxidation states and is believed to undergo changes in oxidation state within the body. Manganese oxidation state can influence tissue toxicokinetic behavior, and possibly toxicity. Manganese is excreted primarily in the faeces. (R441) |
| Toxicity Values |
LD50: 9 g/kg (Oral, Rat) (R293) |
| Lethal Dose |
Not Available |
| Carcinogenicity (IARC Classification) |
Not Available |
| Uses/Sources |
Manganese is used principally in steel production to improve hardness, stiffness, and strength. It may also be used as an additive in gasoline to improve the octane rating of the gas. Manganese ions have various colors and are used industrially as pigments. (R441, R442) |
| Minimum Risk Level |
Chronic Inhalation: 0.0003 mg/m3 (R260) |
| Health Effects |
Manganese mainly affects the nervous system and may cause behavioral changes and other nervous system effects, which include movements that may become slow and clumsy. This combination of symptoms when sufficiently severe is referred to as “manganism”. High levels of manganese may also cause damage to the reproductive system. (R441) |
| Symptoms |
Manganese mainly affects the nervous system and may cause behavioral changes and other nervous system effects, which include movements that may become slow and clumsy. This combination of symptoms when sufficiently severe is referred to as “manganism”. (R441) |
| Treatment |
Not Available |
| General References |
- R442 - Wikipedia. Manganese. Last Updated 26 May 2009.
- R293 - National Institute for Occupational Safety and Health (2002). RTECS: Registry of Toxic Effects of Chemical Substances.
- R260 - ATSDR - Agency for Toxic Substances and Disease Registry (2001). Minimal Risk Levels (MRLs) for Hazardous Substances. U.S. Public Health Service in collaboration with U.S. Environmental Protection Agency (EPA).
- R441 - ATSDR - Agency for Toxic Substances and Disease Registry (2008). Toxicological profile for manganese. U.S. Public Health Service in collaboration with U.S. Environmental Protection Agency (EPA).
|
| Targets |
- Major prion protein
- Putative testis-specific prion protein
- Aconitate hydratase, mitochondrial
- Cytoplasmic aconitate hydratase
- Iron-responsive element-binding protein 2
|
|
Target 1
[top]
|
| Target 1 ID |
633 |
| Target 1 Name |
Major prion protein |
| Target 1 Mechanism of Action |
Manganese binds to the prion protein, altering its conformation, displacing copper, and altering the redox chemistry of the metal-protein complex. These changes are similar to those associated with prion disease. (R443) |
| Target 1 Description |
The physiological function of PrP is not known |
| Target 1 Synonyms |
- PrP; PrP27-30; PrP33-35C; ASCR; CD230 antigen
|
| Target 1 Gene Name |
PRNP |
| Target 1 Protein Sequence |
>Major prion protein
MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQP
HGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGA
VVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCV
NITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPV
ILLISFLIFLIVG
|
| Target 1 Number of Residues |
253 |
| Target 1 Molecular Weight |
27661.2 |
| Target 1 Theoretical pI |
9.23 |
| Target 1 GO Classification |
|
Function
|
| Not Available |
|
Process
|
| Not Available |
|
Component
|
| Not Available |
|
| Target 1 General Function |
Carbohydrate transport and metabolism |
| Target 1 Pathways |
Not Available |
| Target 1 Reactions |
Not Available |
| Target 1 Signals |
|
| Target 1 Transmembrane Regions |
|
| Target 1 Essentiality |
Non Essential |
| Target 1 Domain Function |
PF00377:Prion
PF03991:Prion_octapep |
| Target 1 GenBank ID Protein |
Not Available |
| Target 1 UniProtKB ID |
P04156  |
| Target 1 Cellular Location |
Cell membrane |
| Target 1 Gene Sequence |
>762 bp
GAGCAGTCATTATGGCGAACCTTGGCTGCTGGATGCTGGTTCTCTTTGTGGCCACATGGA
GTGACCTGGGCCTCTGCAAGAAGCGCCCGAAGCCTGGAGGATGGAACACTGGGGGCAGCC
GATACCCGGGGCAGGGCAGCCCTGGAGGCAACCGCTACCCACCTCAGGGCGGTGGTGGCT
GGGGGCAGCCTCATGGTGGTGGCTGGGGGCAGCCTCATGGTGGTGGCTGGGGGCAGCCCC
ATGGTGGTGGCTGGGGACAGCCTCATGGTGGTGGCTGGGGTCAAGGAGGTGGCACCCACA
GTCAGTGGAACAAGCCGAGTAAGCCAAAAACCAACATGAAGCACATGGCTGGTGCTGCAG
CAGCTGGGGCAGTGGTGGGGGGCCTTGGCGGCTACATGCTGGGAAGTGCCATGAGCAGGC
CCATCATACATTTCGGCAGTGACTATGAGGACCGTTACTATCGTGAAAACATGCACCGTT
ACCCCAACCAAGTGTACTACAGGCCCATGGATGAGTACAGCAACCAGAACAACTTTGTGC
ACGACTGCGTCAATATCACAATCAAGCAGCACACGGTCACCACAACCACCAAGGGGGAGA
ACTTCACCGAGACCGACGTTAAGATGATGGAGCGCGTGGTTGAGCAGATGTGTATCACCC
AGTACGAGAGGGAATCTCAGGCCTATTACCAGAGAGGATCGAGCATGGTCCTCTTCTCCT
CTCCACCTGTGATCCTCCTGATCTCTTTCCTCATCTTCCTGA
|
| Target 1 GenBank Gene ID |
Not Available |
| Target 1 GeneCard ID |
PRNP  |
| Target 1 GenAtlas ID |
PRNP  |
| Target 1 HGNC ID |
HGNC:9449  |
| Target 1 Chromosome Location |
Chromosome:20 |
| Target 1 Locus |
20p13 |
| Target 1 SNPs |
SNPJam Report  |
| Target 1 Toxin References |
- R443 - Brazier MW, Davies P, Player E, Marken F, Viles JH, Brown DR: Manganese binding to the prion protein. J Biol Chem. 2008 May 9;283(19):12831-9. Epub 2008 Mar 10. [PubMed
]
|
| Target 1 General References |
3755672; 1678248; 9799790; 10581485; 11780052; 15489334; 3014653; 1363802 |
|
Target 2
[top]
|
| Target 2 ID |
634 |
| Target 2 Name |
Putative testis-specific prion protein |
| Target 2 Mechanism of Action |
Manganese binds to the prion protein, altering its conformation, displacing copper, and altering the redox chemistry of the metal-protein complex. These changes are similar to those associated with prion disease. (R443) |
| Target 2 Description |
Not Available |
| Target 2 Synonyms |
- Protein M8
|
| Target 2 Gene Name |
PRNT |
| Target 2 Protein Sequence |
>Putative testis-specific prion protein
MQHSLVFFFAVILHLSHLLHLDASIHPFRLPFSSKPFLLIPMSNTTLPHTAWPLSFLHQT
VSTLKAVAVTHSLWHLQIPVDCQACNRKSKKIYC
|
| Target 2 Number of Residues |
94 |
| Target 2 Molecular Weight |
10755.7 |
| Target 2 Theoretical pI |
10.00 |
| Target 2 GO Classification |
|
Function
|
| Not Available |
|
Process
|
| Not Available |
|
Component
|
| Not Available |
|
| Target 2 General Function |
Not Available |
| Target 2 Pathways |
Not Available |
| Target 2 Reactions |
Not Available |
| Target 2 Signals |
|
| Target 2 Transmembrane Regions |
|
| Target 2 Essentiality |
Non Essential |
| Target 2 Domain Function |
Not Available |
| Target 2 GenBank ID Protein |
Not Available |
| Target 2 UniProtKB ID |
Q86SH4  |
| Target 2 Cellular Location |
Secreted (Potential) |
| Target 2 Gene Sequence |
>285 bp
ATGCAGCATAGTCTTGTTTTCTTTTTTGCAGTGATTCTACATCTTTCCCATCTTCTCCAC
CTGGATGCCTCCATCCATCCTTTCAGACTTCCCTTCTCTAGCAAACCTTTCTTGCTAATT
CCCATGTCTAACACAACACTTCCCCATACTGCATGGCCATTATCCTTTCTGCATCAGACT
GTGAGCACCTTGAAGGCAGTGGCAGTGACTCATTCATTGTGGCATCTGCAGATTCCAGTG
GACTGCCAGGCATGCAATAGAAAATCAAAAAAGATTTACTGCTAA
|
| Target 2 GenBank Gene ID |
Not Available |
| Target 2 GeneCard ID |
PRNT  |
| Target 2 GenAtlas ID |
PRNT  |
| Target 2 HGNC ID |
HGNC:18046  |
| Target 2 Chromosome Location |
Chromosome:20 |
| Target 2 Locus |
20p13 |
| Target 2 SNPs |
SNPJam Report  |
| Target 2 Toxin References |
- R443 - Brazier MW, Davies P, Player E, Marken F, Viles JH, Brown DR: Manganese binding to the prion protein. J Biol Chem. 2008 May 9;283(19):12831-9. Epub 2008 Mar 10. [PubMed
]
|
| Target 2 General References |
12514748; 11780052; 16460908; 17562432; 17199895 |
|
Target 3
[top]
|
| Target 3 ID |
635 |
| Target 3 Name |
Aconitate hydratase, mitochondrial |
| Target 3 Mechanism of Action |
Manganese interferes with amino acid metabolism by inhibiting aconitase, resulting in an increase in citrate levels. It is also believed that this direct disruption of the catalytic [4Fe-4S] cluster of aconitase by manganese produces iron regulary protein 1, resulting in alterations in cellular iron homeostasis. (R444) |
| Target 3 Description |
Citrate = isocitrate |
| Target 3 Synonyms |
- Aconitase; Citrate hydro-lyase
|
| Target 3 Gene Name |
ACO2 |
| Target 3 Protein Sequence |
>Aconitate hydratase, mitochondrial
MAPYSLLVTRLQKALGVRQYHVASVLCQRAKVAMSHFEPNEYIHYDLLEKNINIVRKRLN
RPLTLSEKIVYGHLDDPASQEIERGKSYLRLRPDRVAMQDATAQMAMLQFISSGLSKVAV
PSTIHCDHLIEAQVGGEKDLRRAKDINQEVYNFLATAGAKYGVGFWKPGSGIIHQIILEN
YAYPGVLLIGTDSHTPNGGGLGGICIGVGGADAVDVMAGIPWELKCPKVIGVKLTGSLSG
WSSPKDVILKVAGILTVKGGTGAIVEYHGPGVDSISCTGMATICNMGAEIGATTSVFPYN
HRMKKYLSKTGREDIANLADEFKDHLVPDPGCHYDQLIEINLSELKPHINGPFTPDLAHP
VAEVGKVAEKEGWPLDIRVGLIGSCTNSSYEDMGRSAAVAKQALAHGLKCKSQFTITPGS
EQIRATIERDGYAQILRDLGGIVLANACGPCIGQWDRKDIKKGEKNTIVTSYNRNFTGRN
DANPETHAFVTSPEIVTALAIAGTLKFNPETDYLTGTDGKKFRLEAPDADELPKGEFDPG
QDTYQHPPKDSSGQHVDVSPTSQRLQLLEPFDKWDGKDLEDLQILIKVKGKCTTDHISAA
GPWLKFRGHLDNISNNLLIGAINIENGKANSVRNAVTQEFGPVPDTARYYKKHGIRWVVI
GDENYGEGSSREHAALEPRHLGGRAIITKSFARIHETNLKKQGLLPLTFADPADYNKIHP
VDKLTIQGLKDFTPGKPLKCIIKHPNGTQETILLNHTFNETQIEWFRAGSALNRMKELQQ
|
| Target 3 Number of Residues |
780 |
| Target 3 Molecular Weight |
85424.7 |
| Target 3 Theoretical pI |
7.65 |
| Target 3 GO Classification |
|
Function
|
carbon-oxygen lyase activity
hydro-lyase activity
aconitate hydratase activity
catalytic activity
lyase activity |
|
Process
|
cellular metabolism
generation of precursor metabolites and energy
energy derivation by oxidation of organic compounds
main pathways of carbohydrate metabolism
tricarboxylic acid cycle
physiological process
metabolism |
|
Component
|
organelle
membrane-bound organelle
intracellular membrane-bound organelle
mitochondrion |
|
| Target 3 General Function |
Energy production and conversion |
| Target 3 Pathways |
Carbohydrate metabolism; tricarboxylic acid cycle |
| Target 3 Reactions |
Not Available |
| Target 3 Signals |
|
| Target 3 Transmembrane Regions |
|
| Target 3 Essentiality |
Non Essential |
| Target 3 Domain Function |
PF00330:Aconitase
PF00694:Aconitase_C |
| Target 3 GenBank ID Protein |
Not Available |
| Target 3 UniProtKB ID |
Q99798  |
| Target 3 Cellular Location |
Mitochondrion (By similarity) |
| Target 3 Gene Sequence |
>2343 bp
ATGGCGCCCTACAGCCTACTGGTGACTCGGCTGCAGAAAGCTCTGGGTGTGCGGCAGTAC
CATGTGGCCTCAGTCCTGTGCCAACGGGCCAAGGTGGCGATGACGCATTTTGAGCCCAAC
GAGTACATCCATTATGACCTGCTAGAGAAGAACATTAACATTGTTCGCAAACGACTGAAC
CGGCCGCTGACACTCTCGGAGAAGATTGTGTATGGACACCTGGATGACCCCGCCAGCCAG
GAAATTGAGCGAGGCAAGTCGTACCTGCGGCTGCGGCCCGACCGTGTGGCCATGCAGGAT
GCGACGGCCCAGATGGCCATGCTCCAGTTCATCAGCAGCGGGCTGTCCAAGGTGGCTGTG
CCATCCACCATCCACTGTGACCATCTGATTGAAGCCCAGGTTGGGGACGAGAAAGACCTG
CGCCGGGCCAAGGACATCAACCAGGAAGTTTATAATTTCCTGGCAACTGCAGGTGACAAG
TATGGCGTGGGCTTCTGGAGCCCTGGATCTGGAATCATTCACCAGATTATTCTCGAAAAC
TATGCGTACCCTGGAGTTCTTCTGATTGGAACTGACTCCCACACCCCCAATGGTGGTGGC
CTAGGAGGCATCTGCATTGGAGTAGGGGGTGCAGATGCTGTGGATGTCATGGCTGGGATC
CCCTGGGAGCTGAAGTGCCCCAAGGTGATTGGCGTGAAGCTGACGGGCTCTCTCTCCGGT
TGGACCTCACCCAAAGATGTGATCCTGAAGGTGGCAGGCATCCTCACGGTGAAAGGTGGC
ACAGGTGCAATCGTGGAATACCACGGGCCTGGTGTAGACTCCATGTCCTGCACTGGCATG
GCGACAATCTGCAACATGGGTGCAGAAATTGGGGCCACCACTTCCGTGTTCCCTTACAAC
CACAGGATGAAGAAGTACCTGAGCAAGACCGGCCGGGAAGACATTGCCAATCTAGCTGAT
GAATTCAAGGATCACTTGGTGCCTGACCCTGGCTGCCATTATGACCAACTAATTGAAATT
AACCTCAGTGAGCTGAAGCCACACATCAATGGGCCCTTCACCCCTGACCTGGCTCACCCT
GTGGCAGAAGTGGGCAAGGTGGCAGAGAAGGAAGGATGGCCTCTGGACATCCGAGTGGGT
CTAATTGGTAGCTGCACCAATTCAAGCTATGAAGATATGGGGCGCTCAGCAGCTGTGGCC
AAGCAGGCACTGGCCCATGGACTCAAGTGCAAGTCCCAGTTCACCATCACTCCAGGTTCC
GAGCAGATCCGCGCCACCATTGAGCGGGACGGCTATGCACAGATCCTGAGGGATCTGGGT
GGCATTGTCCTGGCCAATGCCTGCGGGCCCTGCATTGGCCAGTGGGACAGAAAGGACATC
AAGAAGGGGGAGAAGAACACAATCGTCACCTCCTACAACAGGAACTTCACGGGCCGCAAC
GACGCAAACCCCGAGACCCATGCCTTTGTCACGTCCCCAGAGATTGTCACAGCCCTGGCC
ATTGCAGGAACCCTCAAGTTCAACCCAGAGACCGACTACCTGACAGGCAAGGATGGCAAG
AAGTTCAGGCTGGAAGCTCCGGATGCAGATGAGCTTCCCAAAGGGGAGTTTGACCCAGGG
CAGGACACCTACCAGCACCCCCCAAAGGACAGCAGCAGGCAGCATGTGGACGTGAGCCCC
ACCAGCCAGCGCCTGCAGCTCCTGGAGCCTTTTGACAAGTGGGATGGCAAGGACCTGGAG
GACCTGCAGATCCTCATCAAGGTCAAAGGGAAGTGTACCACTGACCACATCTCAGCTGCT
GGCCCCTGGCTCAAGTTCCGTGGGCACTTGGATAACATCTCCAACAACCTGCTCATTGGT
GCCATCAACATTGAAAACGGCAAGGCCAACTCCGTGCGCAATGCCGTCACTCAGGAGTTT
GGCCCCGTCCCTGACACTGCCCGCTACTACAAGAAACATGGCATCAGGTGGGTGGTGATC
GGAGACGAGAACTACGGCGAGGGCTCGAGCCGGGAGCATGCAGCTCTGGAGCCTCGCCAC
CTTGGGGGCCGGGCCATCATCACCAAGAGCTTTGCCAGGATCCACGAGACCAACCTGAAG
AAACAGGGCCTGCTGCCTCTGACCTTCGCTGACCCGGCTGACTACAACAAGATTCACCCT
GTGGACAAGCTGACCATTCAGGGCCTGAAGGACTTCACCCCTGGCAAGCCCCTGAAGTGC
ATCATCAAGCACCCCAACGGGACCCAGGAGACCATCCTCCTGAACCACACCTTCAACGAG
ACGCAGATTGAGTGGTTCCGCGCTGGCAGTGCCCTCAACAGAATGAAGGAACTGCAACAG
TGA
|
| Target 3 GenBank Gene ID |
Not Available |
| Target 3 GeneCard ID |
ACO2  |
| Target 3 GenAtlas ID |
ACO2  |
| Target 3 HGNC ID |
HGNC:118  |
| Target 3 Chromosome Location |
Chromosome:22 |
| Target 3 Locus |
22q11.2-q13.31|22q13.2|22q13.2-q13.31 |
| Target 3 SNPs |
SNPJam Report  |
| Target 3 Toxin References |
- R444 - Crooks DR, Ghosh MC, Braun-Sommargren M, Rouault TA, Smith DR: Manganese targets m-aconitase and activates iron regulatory protein 2 in AF5 GABAergic cells. J Neurosci Res. 2007 Jun;85(8):1797-809. [PubMed
]
|
| Target 3 General References |
9630632; 15461802; 10591208; 15489334; 1946331; 16959974 |
|
Target 4
[top]
|
| Target 4 ID |
636 |
| Target 4 Name |
Cytoplasmic aconitate hydratase |
| Target 4 Mechanism of Action |
Manganese interferes with amino acid metabolism by inhibiting aconitase, resulting in an increase in citrate levels. It is also believed that this direct disruption of the catalytic [4Fe-4S] cluster of aconitase by manganese produces iron regulary protein 1, resulting in alterations in cellular iron homeostasis. (R444) |
| Target 4 Description |
Binds to iron-responsive elements (IRES), which are stem-loop structures found in the 5'-UTR of ferritin, and delta aminolevulinic acid synthase mRNAs, and in the 3'-UTR of transferrin receptor mRNA. Binding to the IRE element in ferritin results in the repression of its mRNA translation. Binding of the protein to the transferrin receptor mRNA inhibits the degradation of this otherwise rapidly degraded mRNA. This protein also expresses aconitase activity |
| Target 4 Synonyms |
- Aconitase; Citrate hydro-lyase; Iron-responsive element-binding protein 1; IRE-BP 1; Iron regulatory protein 1; IRP1; Ferritin repressor protein
|
| Target 4 Gene Name |
ACO1 |
| Target 4 Protein Sequence |
>Cytoplasmic aconitate hydratase
MSNPFAHLAEPLDPVQPGKKFFNLNKLEDSRYGRLPFSIRVLLEAAIRNCDEFLVKKQDI
ENILHWNVTQHKNIEVPFKPARVILQDFTGVPAVVDFAAMRDAVKKLGGDPEKINPVCPA
DLVIDHSIQVDFNRRADSLQKNQDLEFERNRERFEFLKWGSQAFHNMRIIPPGSGIIHQV
NLEYLARVVFDQDGYYYPDSLVGTDSHTTMIDGLGILGWGVGGIEAEAVMLGQPISMVLP
QVIGYRLMGKPHPLVTSTDIVLTITKHLRQVGVVGKFVEFFGPGVAQLSIADRATIANMC
PEYGATAAFFPVDEVSITYLVQTGRDEEKLKYIKKYLQAVGMFRDFNDPSQDPDFTQVVE
LDLKTVVPCCSGPKRPQDKVAVSDMKKDFESCLGAKQGFKGFQVAPEHHNDHKTFIYDNT
EFTLAHGSVVIAAITSCTNTSNPSVMLGAGLLAKKAVDAGLNVMPYIKTSLSPGSGVVTY
YLQESGVMPYLSQLGFDVVGYGCMTCIGNSGPLPEPVVEAITQGDLVAVGVLSGNRNFEG
RVHPNTRANYLASPPLVIAYAIAGTIRIDFEKEPLGVNAKGQQVFLKDIWPTRDEIQAVE
RQYVIPGMFKEVYQKIETVNESWNALATPSDKLFFWNSKSTYIKSPPFFENLTLDLQPPK
SIVDAYVLLNLGDSVTTDHISPAGNIARNSPAARYLTNRGLTPREFNSYGSRRGNDAVMA
RGTFANIRLLNRFLNKQAPQTIHLPSGEILDVFDAAERYQQAGLPLIVLAGKEYGAGSSR
DWAAKGPFLLGIKAVLAESYERIHRSNLVGMGVIPLEYLPGENADALGLTGQERYTIIIP
ENLKPQMKVQVKLDTGKTFQAVMRFDTDVELTYFLNGGILNYMIRKMAK
|
| Target 4 Number of Residues |
889 |
| Target 4 Molecular Weight |
98398.1 |
| Target 4 Theoretical pI |
6.66 |
| Target 4 GO Classification |
|
Function
|
ion binding
cation binding
transition metal ion binding
iron ion binding
carbon-oxygen lyase activity
hydro-lyase activity
aconitate hydratase activity
binding
nucleic acid binding
RNA binding
catalytic activity
lyase activity |
|
Process
|
physiological process
metabolism |
|
Component
|
| Not Available |
|
| Target 4 General Function |
Energy production and conversion |
| Target 4 Pathways |
Not Available |
| Target 4 Reactions |
Not Available |
| Target 4 Signals |
|
| Target 4 Transmembrane Regions |
|
| Target 4 Essentiality |
Non Essential |
| Target 4 Domain Function |
PF00330:Aconitase
PF00694:Aconitase_C |
| Target 4 GenBank ID Protein |
Not Available |
| Target 4 UniProtKB ID |
P21399  |
| Target 4 Cellular Location |
Cytoplasm |
| Target 4 Gene Sequence |
>2670 bp
ATGAGCAACCCATTCGCACACCTTGCTGAGCCATTGGATCCTGTACAACCAGGAAAGAAA
TTCTTCAATTTGAATAAATTGGAGGATTCAAGATATGGGCGCTTACCATTTTCGATCAGA
GTTCTTCTGGAAGCAGCCATTCGGAATTGTGATGAGTTTTTGGTGAAGAAACAGGATATT
GAAAATATTCTACATTGGAATGTCACTCAGCACAAGAACATAGAAGTGCCATTTAAGCCT
GCTCGTGTCATCCTGCAGGACTTTACGGGTGTGCCCGCTGTGGTTGACTTTGCTGCAATG
CGTGATGCTGTGAAAAAGTTAGGAGGAGATCCAGAGAAAATAAACCCTGTCTGCCCTGCT
GATCTTGTAATAGATCATTCCATCCAGGTTGATTTCAACAGAAGGGCAGACAGTTTACAG
AAGAATCAAGACCTGGAATTTGAAAGAAATAGAGAGCGATTTGAATTTTTAAAGTGGGGT
TCCCAGGCTTTTCACAACATGCGGATTATTCCCCCTGGCTCAGGAATCATCCACCAGGTG
AATTTGGAATATTTGGCAAGAGTGGTATTTGATCAGGATGGATATTATTACCCAGACAGC
CTCGTGGGCACAGACTCGCACACTACCATGATTGATGGCTTGGGCATTCTTGGTTGGGGT
GTCGGTGGTATTGAAGCAGAAGCTGTCATGCTGGGTCAGCCAATCAGTATGGTGCTTCCT
CAGGTGATTGGCTACAGGCTGATGGGGAAGCCCCACCCTCTGGTAACATCCACTGACATC
GTGCTCACCATTACCAAGCACCTCCGCCAGGTTGGGGTAGTGGGCAAATTTGTCGAGTTC
TTCGGGCCTGGAGTAGCCCAGTTGTCCATTGCTGACCGAGCTACGATTGCTAACATGTGT
CCAGAGTACGGAGCAACTGCTGCCTTTTTCCCAGTTGATGAAGTTAGTATCACGTACCTG
GTGCAAACAGGTCGTGATGAAGAAAAATTAAAGTATATTAAAAAATATCTTCAGGCTGTA
GGAATGTTTCGAGATTTCAATGACCCTTCTCAAGACCCAGACTTCACCCAGGTTGTGGAA
TTAGATTTGAAAACAGTAGTGCCTTGCTGTAGTGGACCCAAAAGGCCTCAGGACAAAGTT
GCTGTGTCCGACATGAAAAAGGACTTTGAGAGCTGCCTTGGAGCCAAGCAAGGATTTAAA
GGATTCCAAGTTGCTCCTGAACATCATAATGACCATAAGACCTTTATCTATGATAACACT
GAATTCACCCTTGCTCATGGTTCTGTGGTCATTGCTGCCATTACTAGCTGCACAAACACC
AGTAATCCGTCTGTGATGTTAGGGGCAGGATTGTTAGCAAAGAAAGCTGTGGATGCTGGC
CTGAACGTGATGCCTTACATCAAAACTAGCCTGTCTCCTGGGAGTGGCGTGGTCACCTAC
TACCTACAAGAAAGCGGAGTCATGCCTTATCTGTCTCAGCTTGGGTTTGACGTGGTGGGC
TATGGCTGCATGACCTGCATTGGCAACAGTGGGCCTTTACCTGAACCTGTGGTAGAAGCC
ATCACACAGGGAGACCTTGTAGCTGTTGGAGTACTATCTGGAAACAGGAATTTTGAAGGT
CGAGTTCACCCCAACACCCGGGCCAACTATTTAGCCTCTCCCCCCTTAGTAATAGCATAT
GCAATTGCTGGAACCATCAGAATCGACTTTGAGAAAGAGCCATTGGGAGTAAATGCAAAG
GGACAGCAGGTATTTCTGAAAGATATCTGGCCGACTAGAGACGAGATCCAGGCAGTGGAG
CGTCAGTATGTCATCCCGGGGATGTTTAAGGAAGTCTATCAGAAAATAGAGACTGTGAAT
GAAAGCTGGAATGCCTTAGCAACCCCATCAGATAAGCTGTTTTTCTGGAATTCCAAATCT
ACGTATATCAAATCACCACCATTCTTTGAAAACCTGACTTTGGATCTTCAGCCCCCTAAA
TCTATAGTGGATGCCTATGTGCTGCTAAATTTGGGAGATTCGGTAACAACTGACCACATC
TCCCCAGCTGGAAATATTGCAAGAAACAGTCCTGCTGCTCGCTACTTAACTAACAGAGGC
CTAACTCCACGAGAATTCAACTCCTATGGCTCCCGCCGAGGTAATGACGCCGTCATGGCA
CGGGGAACATTTGCCAACATTCGCTTGTTAAACAGATTTTTGAACAAGCAGGCACCACAG
ACTATCCATCTGCCTTCTGGGGAAATCCTTGATGTGTTTGATGCTGCTGAGCGGTACCAG
CAGGCAGGCCTTCCCCTGATCGTTCTGGCTGGCAAAGAGTACGGTGCAGGCAGCTCCCGA
GACTGGGCAGCTAAGGGCCCTTTCCTGCTGGGAATCAAAGCCGTCCTGGCCGAGAGCTAC
GAGCGCATTCACCGCAGTAACCTGGTTGGGATGGGTGTGATCCCACTTGAATATCTCCCT
GGTGAGAATGCAGATGCCCTGGGGCTCACAGGGCAAGAACGATACACTATCATTATTCCA
GAAAACCTCAAACCACAAATGAAAGTCCAGGTCAAGCTGGATACTGGCAAGACCTTCCAG
GCTGTCATGAGGTTTGACACTGATGTGGAGCTCACTTATTTCCTCAACGGGGGCATCCTC
AACTACATGATCCGCAAGATGGCCAAGTAG
|
| Target 4 GenBank Gene ID |
Not Available |
| Target 4 GeneCard ID |
ACO1  |
| Target 4 GenAtlas ID |
ACO1  |
| Target 4 HGNC ID |
HGNC:117  |
| Target 4 Chromosome Location |
Not Available |
| Target 4 Locus |
9p22-q32|9p21.1 |
| Target 4 SNPs |
SNPJam Report  |
| Target 4 Toxin References |
- R444 - Crooks DR, Ghosh MC, Braun-Sommargren M, Rouault TA, Smith DR: Manganese targets m-aconitase and activates iron regulatory protein 2 in AF5 GABAergic cells. J Neurosci Res. 2007 Jun;85(8):1797-809. [PubMed
]
|
| Target 4 General References |
1738601; 15489334; 2172968; 1903202; 1946430 |
|
Target 5
[top]
|
| Target 5 ID |
637 |
| Target 5 Name |
Iron-responsive element-binding protein 2 |
| Target 5 Mechanism of Action |
Manganese alters cellular iron homeostasis by stabilizing iron regulatory protein 2. This may occur by manganese competing directly for an iron-binding site on the iron binding protein, disrupting the cellular mechanisms responsible for its iron-dependent degradation. (R444) |
| Target 5 Description |
Binds to iron-responsive elements (IRES), which are stem-loop structures found in the 5'-UTR of ferritin, and delta aminolevulinic acid synthase mRNAs, and in the 3'-UTR of transferrin receptor mRNA. Binding to the IRE element in ferritin results in the repression of its mRNA translation. Binding of the protein to the transferrin receptor mRNA inhibits the degradation of this otherwise rapidly degraded mRNA |
| Target 5 Synonyms |
- IRE-BP 2; Iron regulatory protein 2; IRP2
|
| Target 5 Gene Name |
IREB2 |
| Target 5 Protein Sequence |
>Iron-responsive element-binding protein 2
MDAPKAGYAFEYLIETLNDSSHKKFFDVSKLGTKYDVLPYSIRVLLEAAVRNCDGFLMKK
EDVMNILDWKTKQSNVEVPFFPARVLLQDFTGIPAMVDFAAMREAVKTLGGDPEKVHPAC
PTDLTVDHSLQIDFSKCAIQNAPNPGGGDLQKAGKLSPLKVQPKKLPCRGQTTCRGSCDS
GELGRNSGTFSSQIENTPILCPFHLQPVPEPETVLKNQEVEFGRNRERLQFFKWSSRVFK
NVAVIPPGTGMAHQINLEYLSRVVFEEKDLLFPDSVVGTDSHITMVNGLGILGWGVGGIE
TEAVMLGLPVSLTLPEVVGCELTGSSNPFVTSIDVVLGITKHLRQVGVAGKFVEFFGSGV
SQLSIVDRTTIANMCPEYGAILSFFPVDNVTLKHLEHTGFSKAKLESMETYLKAVKLFRN
DQNSSGEPEYSQVIQINLNSIVPSVSGPKRPQDRVAVTDMKSDFQACLNEKVGFKGFQIA
AEKQKDIVSIHYEGSEYKLSHGSVVIAAVISCTNNCNPSVMLAAGLLAKKAVEAGLRVKP
YIRTSLSPGSGMVTHYLSSSGVLPYLSKLGFEIVGYGCSTCVGNTAPLSDAVLNAVKQGD
LVTCGILSGNKNFEGRLCDCVRANYLASPPLVVAYAIAGTVNIDFQTEPLGTDPTGKNIY
LHDIWPSREEVHRVEEEHVILSMFKALKDKIEMGNKRWNSLEAPDSVLFPWDLKSTYIRC
PSFFDKLTKEPIALQAIENAHVLLYLGDSVTTDHISPAGSIARNSAAAKYLTNRGLTPRE
FNSYGARRGNDAVMTRGTFANIKLFNKFIGKPAPKTIHFPSGQTLDVFEAAELYQKEGIP
LIILAGKKYGSGNSRDWAAKGPYLLGVKAVLAESYEKIHKDHLIGIGIAPLQFLPGENAD
SLGLSGRETFSLTFPEELSPGITLNIQTSTGKVFSVIASFEDDVEITLYKHGGLLNFVAR
KFS
|
| Target 5 Number of Residues |
963 |
| Target 5 Molecular Weight |
105045.6 |
| Target 5 Theoretical pI |
7.05 |
| Target 5 GO Classification |
|
Function
|
ion binding
cation binding
transition metal ion binding
iron ion binding
carbon-oxygen lyase activity
hydro-lyase activity
aconitate hydratase activity
binding
nucleic acid binding
RNA binding
catalytic activity
lyase activity |
|
Process
|
physiological process
metabolism |
|
Component
|
| Not Available |
|
| Target 5 General Function |
Energy production and conversion |
| Target 5 Pathways |
Not Available |
| Target 5 Reactions |
Not Available |
| Target 5 Signals |
|
| Target 5 Transmembrane Regions |
|
| Target 5 Essentiality |
Non Essential |
| Target 5 Domain Function |
PF00330:Aconitase
PF00694:Aconitase_C |
| Target 5 GenBank ID Protein |
Not Available |
| Target 5 UniProtKB ID |
P48200  |
| Target 5 Cellular Location |
Cytoplasm |
| Target 5 Gene Sequence |
Not Available |
| Target 5 GenBank Gene ID |
Not Available |
| Target 5 GeneCard ID |
IREB2  |
| Target 5 GenAtlas ID |
IREB2  |
| Target 5 HGNC ID |
HGNC:6115  |
| Target 5 Chromosome Location |
Chromosome:15 |
| Target 5 Locus |
15q25.1 |
| Target 5 SNPs |
SNPJam Report  |
| Target 5 Toxin References |
- R444 - Crooks DR, Ghosh MC, Braun-Sommargren M, Rouault TA, Smith DR: Manganese targets m-aconitase and activates iron regulatory protein 2 in AF5 GABAergic cells. J Neurosci Res. 2007 Jun;85(8):1797-809. [PubMed
]
|
| Target 5 General References |
7983023; 14702039; 16572171; 15489334; 2172968; 7622457 |